All Pharma News
Dana-Farber’s computer platform makes patient matching process easier

Dana-Farber’s computer platform makes patient matching process easier
CLINICALTRIALSARENA
14 Oct 2022
Share Share
Dana-Farber CEO Laurie Glimcher resigns from GSK board

Dana-Farber CEO Laurie Glimcher resigns from GSK board
Zachary Brennan ENDPTS
29 Jul 2022
Share Share
Novel cancer vaccines look beyond T cells to better fight tumors

Novel cancer vaccines look beyond T cells to better fight tumors
Angus Liu FIERCEBIOTECH
27 May 2022
Share Share
Varsity Pharmaceuticals Licenses Pol-Theta Inhibitor

Varsity Pharmaceuticals Licenses Pol-Theta Inhibitor
BUSINESSWIRE
07 Feb 2022
Share Share
BAKX nets more cash for its `Thelma and Louise` approach to cancer cell death

BAKX nets more cash for its `Thelma and Louise` approach to cancer cell death
Nicole DeFeudis ENDPTS
18 Nov 2021
Share Share
Eureka Initiates Phase I/II ARYA-2 Trial of ET140203 ARTEMIS T Cells

Eureka Initiates Phase I/II ARYA-2 Trial of ET140203 ARTEMIS T Cells
BUSINESSWIRE
17 Nov 2021
Share Share
Lew Cantley is headed to Dana-Farber

Lew Cantley is headed to Dana-Farber
John Carroll ENDPTS
11 Nov 2021
Share Share
Renowned Dana-Farber scientist, David Livingston has died

Renowned Dana-Farber scientist, David Livingston has died
John Carroll ENDPTS
20 Oct 2021
Share Share
Luba Greenwood takes the helm at Kojin Therapeutics; Alexion R&D chief packs up

Luba Greenwood takes the helm at Kojin Therapeutics; Alexion R&D chief packs up
Alex Hoffmann ENDPTS
15 Oct 2021
Share Share
Kojin Therapeutics Announces Luba Greenwood as Chief Executive Officer

Kojin Therapeutics Announces Luba Greenwood as Chief Executive Officer
BUSINESSWIRE
14 Oct 2021
Share Share